alexa A Brief Summary for 5-HT Receptors | Open Access Journals
ISSN: 2157-7412
Journal of Genetic Syndromes & Gene Therapy
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

A Brief Summary for 5-HT Receptors

Watry S and Lu J*

Department of Neuroscience and Department of Neurology, School of Medicine and Public Health, Waisman Center, University of Wisconsin, Madison, WI 53705, USA

*Corresponding Author:
Jianfeng Lu
Waisman Center, University of Wisconsin
Madison, WI 53705, USA
E-mail: [email protected]

Received date: February 26, 2013; Accepted date:March 07, 2013; Published date: March 11, 2013

Citation: Watry S, Lu J (2013) A Brief Summary for 5-HT Receptors. J Genet Syndr Gene Ther 4:129. doi:10.4172/2157-7412.1000129

Copyright: © 2013 Watry S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Genetic Syndromes & Gene Therapy

As a group of G protein-coupled receptors (GPCRs) and ligandgated ion channels (LGICs), the serotonin (5-HT) receptors are found in the central and peripheral nervous systems. After activated by the neurotransmitter serotonin, their natural ligand, 5-HT receptors mediate both excitatory and inhibitory neurotransmission by modulating the release of many neurotransmitters, including glutamate, GABA, dopamine, epinephrine/norepinephrine, and acetylcholine, as well as many hormones, including oxytocin, prolactin, vasopressin, cortisol, corticotropin, and substance P, among others. 5-HT receptors influence various biological and neurological processes such as aggression, anxiety, appetite, cognition, learning, memory, mood, nausea, sleep, and thermoregulation. Accordingly, 5-HT receptors are the target of a variety of pharmaceutical drugs, including many antidepressants, antipsychotics, anorectics, antiemetics, gastroprokinetic agents, antimigraine agents, hallucinogens, and entactogens.

In order to help the potential readers to understand the complicated network of 5-HT receptors, here we try to summarize the comprehensive information on 5-HT receptors in a concise summary with detailed references, which may help the readers for further information excavation.

Receptor: 5-HT 1A [1]

Structure: GPCR [2]

Localization: Soma; dendrites, axon hillock, cell body and process of astrocytes, Cornu Ammonus, Hilus of Dentate Gyrus, Locus Coeruleus, Cervical Spinal Cord, Pontine Nuclei, Brainstem Tectum, White Matter of Cerebral Cortex, White Matter of Spinal Cord, Reticular neruons in brain stem, Dorsal Rahpe Nuclei [3]; Midbrain Rahpe Nuclei [4]; Anterior Raphe Nuclei [5]; Hippocampus, Septum [1].

Selective antagonist: WAY 100 635 [6]; (S)-UH301 [7]; NAD 299(Robalzotan) [8]; Spiroxatrine [9]; Idocyanopinolol [10]; SB 272183 [11]; SB 649915 [12]; GSK588045 [13].

Selective agonist: 8-OH-DPAT [14]; U 92016A [15]; ipsapirone [16]; F 15599 [17]; N-Desalkylquetiapine [18]; BP 554 [19]; DMT (Dimethyltryptamine) [20].

Application value: Epilepsy [21]; Anxiety/Depression [22]; Panic disorder [23]; Aggression [24]; Cognition [25]; Schizophrenia [26]; hypothermia [27]; hyperphagia [28].

Receptor: 5-HT 1B [29]

Structure: GPCR [29].

Localization: CNS: Axon terminals [4,30]; Globus Pallidus, Substantia Nigra [31]; Caudate Nucleus, Lateral Geniculate Nuclei, Spinal Trigominal Nucleus [32].

Selective antagonist: GR 55562 [33]; SB 224289 [34]; SB 236057 [35]; Cyanopindolol; NAS - 181α [36]; GR 127935 [37]; SB 272183 [11]; AR-A000002 [38]; SB 649915 [12]; SB-616234-A [39]; GSK588045 [13].

Selective agonist: L 694247 [40]; CP-94253 [41]; D 16949 (Anpirtoline) [42]; CGS 12066B [43]; SB 216641 [44]; RU 24969 [45]; CP 93129 [46].

Application value: Depression [47]; Anxiety [48]; Aggression [49]; Migraine [50]; Drug Addicton [51]; increased locomotor activity [52]; brain reward mechanisms (agonist); Alcoholism [53]; Sleep [54]; hypothermia [55].

Receptor: 5-HT 1D [56]

Structure: GPCR [56].

Localization: Raphe nuclei; Cortex, Caudate, Globus Pallidus [57]; Basal Ganglia, Substantia Nigra, Hippocampal Formation, Raphe Nuclei [58]; Caudate Nucleus, Lateral Geniculate Nuclei, Spinal Trigominal Nucleus [32]; Globus Pallidus [59].

Selective antagonist: GR 55562 [33]; SB 224289 [34]; SB 236057 [35]; Cyanopindolol; NAS - 181α [36]; GR 127935 [37]; SB 272183 [11]; AR-A000002 [38]; SB 649915 [12]; SB-616234-A [39]; GSK588045 [13].

Selective agonist: BRL 15572α [44]; SB 714786 [60]; GR 127935 [37]; SB 272183 [11]; GSK588045 [13].

Application value: Migraine [64].

Receptor: 5-HT 1F [65]

Structure: GPCR

Localization: Cortex, Claustrum [66]; Caudate, Putamen [59].

Receptor: 5-HT 1F [67]

Structure: GPCR

Localization: Intermediate Neocortical Layers, Mammillary Nuclei, Thalamic Nuclei, Claustrum, Intermidiate Cortical Layers, Parafascicular Nucleus, Caudate Nucleus, Lateral Geniculate Nuclei, Spinal Trigominal Nucleus [32].

Selective agonist: LY 344864 [68]; Sumatripatan [32].

Application value: Migraines [68].

Receptor: 5-HT 2A

Structure: GPCR

Localization: Olfactory Bulb, Neocortex, Claustrum, Piriform Cortex, Mammilllary Bodies, Pontine Nuclei, Red Nuclei, Cranial Motor Nuclei [69]; Plasma Membrane, T-Tubules in Contracting Myotubes, Skeletal Muscle Myoblasts [70].

Selective antagonist: Ketanserin [10]; “(1R, 3S)-(−)-Trans-PAT [71]; α R-96544 [72].

Application value: Depression [73]; anxiety [74]; schizophrenia [75]; eating disorders [76]; sleep disorder [77].

Receptor: 5-HT 2B [78]

Structure: GPCR

Localization: Pancreas, Liver, Kidney [79]; AV12-664 [79]

Selective antagonist: RS 127445 [81]; SB 200646 [82]; SB 204741[83]; SB 206553 [84]; SDZ HTF 919 (Tegaserod) [85]; “(1R, 3S)- (−)-Trans-PAT [71]; SB 215505 [86].

Selective agonist: BW 723C86 [87]

Application value: Depression [88]; anxiety [74]; sleep disorder [89]; Migraines [90].

Receptor: 5-HT 2C [90]

Structure: GPCR [90]

Localization: Choroid Plexus [91]; Frontal Cortex, Septum, Hypothalamus [92]; Striatum [91]; Thalamus, Midbrain, Brain Stem, Cerebellum, Spinal Cord [92]; Hippocampus, Cerebral Cortex, Substantia Nigra [91]; Intestine, Heart, Kidney [90].

Selective antagonist: SB 242084 [93]; RS 102221 [94]; N-desmethylclozapine [95]; SB 200646 [82]; SB 206553 [84]; S32212 [96]; Clozapine [95].

Selective agonist: Ro600175; Lorcaserin [97]; WAY-163909 [36]; YM 348 [98]; (1R, 3S)-(−)-Trans-PAT [71].

Application value: anxiety [99]; obesity [100]; cognition.

Receptor: 5-HT 3 [101]

Structure: LGIC

Localization: Limbic Area, Striatal Area [102] Hippocampus, Amygdala, Cortical Area [103]; Putamen, Nucleus accumbens, Caudate Nucleus [104].

Selective antagonist: Granisetron (BRL 43694) [105]; Ondansetron [106]; Tropisetron [107]; Y-25130 [108]; Zacopride [109]; Renapride [40]; BRL 46470 [110]; VA21B7 [111]; N-3389 [112]; DAU 6215 [113].

Selective agonist: SR 57227A [114]; m-chlorophenyl-biguanide [115]; Azilsartan [113]; YM 31636 [116].

Application value: Anxiety [117]; SIDS [118]; Emisis [119]; Irritable Bowel Syndrome [120].

Receptor: 5-HT 4 [121]

Structure: GPCR [122].

Localization: Atrium [123]; GI Tract [124]; Striatum [121].

Selective antagonist: GR 113808 [125]; SB 204070 [126]; RS 100235 [127]; α RS 39604 [128]; SDZ 205, 557α [129]; RS 23957-190 [130]; SB 207266 [131], DAU 6285 [132]; N-3389 [112].

Selective agonist: BIMU 8 [133]; RS 67506 [134]; ML 10302 [135]; BIMU 1 [133]; zacopride [109]; RS 67333 [134]; L-Lysine [136]; PF-01354082 [137]; TS 951 [138]; SK-951 [139]; CJ 033466 [140]; SL65.0155 [141]; DAU 6215 [133].

Application value: Cognition [141]; anxiety [142]; Learning [143]; Emisis [144]; Emotions, Reward Systems, Memory, Motor Activity [145]; Irritable Bowel Syndrome [120].

Receptor: 5-HT 5A [146]

Structure: GPCR

Selective antagonist: SB 699551-A [147].

Selective agonist: 5-CT; Valerian [148]; Valerenic Acid [148]

Application value: Unknown

Receptor: 5-HT 5B [149]

Structure: GPCR

Selective agonist: 5-CT

Application value: Unknown

Receptor: 5-HT 6 [78]

Structure: GPCR

Localization: Olfactory tubercle [78]; striatum; nucleus accumbens; hippocampus; cerebral cortex; Stomach [78].

Selective antagonist: Ro 630563 [150]; SB 271046 [151]; SB 357134 [152]; Ro 046790 [153].

Application value: cognition [153]; schizophrenia [154]; depression [155]; anxiety [155]; stress; epilepsy [21]; obesity [156].

Receptor: 5-HT 7 [157]

Structure: GPCR

Localization: Pyramidal hippocampus; tenia tecta; amygdaloid; mammillary nuclei [157].

Selective antagonist: SB 258719 [158]; SB 269970 [159,160]; SB 656104 [161]; SB 258741 [162]

Selective agonist: 8-OH-DPAT [163]

Application value: Depression [164]; schizophrenia [154]; sleep disorder [165]; epilepsy [21]; cognition [166]; Anxiety [167]; OCD [168]; Mood, learning, neuroendocrine behaviours, vegetative behaviours [157].

References

 

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 10th International Conference on Genomics and Molecular Biology
    May 21-23, 2018 Barcelona, Spain
  • 5th International Conference on Human Genetics and Genetic Disorders September 21-22,2018 Philadelphia, USA Theme: Sharing Discoveries of the Future Human Genome
    September 21-22,2018 Philadelphia, USA
  • 3rd World Congress on Human Genetics & Genetic Disorders
    October 20-21, 2017 Toronto, Canada

Article Usage

  • Total views: 11834
  • [From(publication date):
    March-2013 - Nov 25, 2017]
  • Breakdown by view type
  • HTML page views : 8039
  • PDF downloads : 3795
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords